Velcade
Showing 626 - 641 of 641
Colorectal Carcinoma Trial in United States (VELCADE TM (bortezomib) for Injection, or PS-341)
Completed
- Colorectal Carcinoma
- VELCADE TM (bortezomib) for Injection, or PS-341
-
Birmingham, Alabama
- +21 more
Feb 7, 2008
NSCLC Trial in United States (VELCADEā¢ (bortezomib) for Injection (formerly PS-341))
Completed
- Non-Small Cell Lung Cancer
- VELCADEā¢ (bortezomib) for Injection (formerly PS-341)
-
Birmingham, Alabama
- +19 more
Feb 7, 2008
B-Cell Lymphoma, Follicular Lymphoma, Marginal Lymphoma Trial in United States (VELCADE and rituximab)
Completed
- B-Cell Lymphoma
- +2 more
- VELCADE and rituximab
-
Los Angeles, California
- +12 more
Feb 7, 2008
Prostatic Tumors Trial in United States (VELCADE TM (bortezomib) for Injection)
Completed
- Prostatic Neoplasms
- VELCADE TM (bortezomib) for Injection
-
Los Angeles, California
- +3 more
Feb 7, 2008
Multiple Myeloma Trial in United States (ATN-224 + bortezomib)
Terminated
- Multiple Myeloma
- ATN-224 + bortezomib
-
Fresno, California
- +9 more
Oct 27, 2008
Tumors Trial in Pittsburgh (bortezomib)
Completed
- Tumors
-
Pittsburgh, PennsylvaniaMedical Center, UPMC Cancer Pavilion
Feb 7, 2008
Mantle Cell Lymphoma Trial in United States (VELCADE TM (bortezomib) for Injection)
Completed
- Mantle Cell Lymphoma
- VELCADE TM (bortezomib) for Injection
-
Birmingham, Alabama
- +34 more
Feb 7, 2008
Lymphoma Trial in Charlottesville (bortezomib, rituximab, antibody therapy)
Terminated
- Lymphoma
- bortezomib
- +5 more
-
Charlottesville, VirginiaUniversity of Virginia Cancer Center at UV Health System
Jan 24, 2008
Cervical Cancer Trial in Providence (Velcade (bortezomib), Irinotecan)
Terminated
- Cervical Cancer
- Velcade (bortezomib)
- Irinotecan
-
Providence, Rhode IslandWomen & Infants' Hospital
Apr 17, 2007
Multiple Myeloma Trial in Seoul (velcade)
Unknown status
- Multiple Myeloma
- velcade
-
Seoul, Korea, Republic ofSeoul National University Hospital
Sep 21, 2006
Multiple Myeloma Trial in Inchon (Velcade, Thalidomide, Adriamycin)
Unknown status
- Multiple Myeloma
- Velcade
- +3 more
-
Inchon, Korea, Republic ofGachon University Gil Hospital
Apr 28, 2006
Advanced NSCLC, Other Solid Tumors Trial (VELCADE TM (bortezomib) for Injection, or PS-341)
Terminated
- Advanced Non-Small Cell Lung Cancer
- Other Solid Tumors
- VELCADE TM (bortezomib) for Injection, or PS-341
- (no location specified)
Jun 23, 2005